Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy

Figure 3

Kaplan–Meier survival plot of overall survival (OS) by KRAS genotype. (a) OS was significantly worse in patients with wild type KRAS and strong CIP2A expression, compared with patients with wild type KRAS and weak CIP2A expression (P = 0.035). (b) No difference in OS associated with CIP2A expression was observed in mutant KRAS patients (P = 0.759).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us